Clinical trials
Recruiting Primary Myelofibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
90 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 8 |
| 2023 | 13 |
| 2024 | 17 |
| 2025 | 14 |
| 2026 | 21 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 90 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 3 |
| Incyte Corporation | 3 |
| M.D. Anderson Cancer Center | 3 |
| University Hospital, Angers | 3 |
| Center for International Blood and Marrow Transplant Research | 2 |
| City of Hope Medical Center | 2 |
| Fred Hutchinson Cancer Center | 2 |
| Icahn School of Medicine at Mount Sinai | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| Takeda | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 90 |
| Myeloproliferative Disorders | 28 |
| Thrombocythemia, Essential | 25 |
| Myelodysplastic Syndromes | 20 |
| Polycythemia Vera | 20 |
| Leukemia, Myeloid, Acute | 16 |
| Leukemia, Myelomonocytic, Chronic | 11 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 11 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 10 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 9 |
Trials
Showing 51 to 75 of 90. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.